Quantus

Xencor financial statements

NASDAQ:XNCR · Nasdaq · Healthcare · sector #16
$33.26-2.21%Nov 20 close

Xencor's published financial data is dated 2026-11-22. 2024 revenue was $110M. 2024 operating profit was −$199M.

Reported results

Financial safety

Reference indicatorAs of 2024
Grey zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 2.16
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
2.16
Beneish M-Score
3.62

Statistical manipulation-risk signal

Sloan accrual
-3.20%

These are factual indicators of distress and manipulation risk. They are not investment advice and are for reference only, as they have not yet been validated.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7 (new share issuance) is approximated by whether equity/assets was maintained (at least 95% of the prior year).

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -183%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업이익률 악화 (-82.4% → -180.0%, -97.6%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-180%
Interest coverage
-5.4x
Return on equity (ROE)
-34.3%

Operating margin −5pp

Operating loss
Interest coverageBase -5.4x adverse case -5.6x
Return on equity (ROE)Base -34.3% adverse case -35.6%

Revenue −15%

Interest coverage risk
Interest coverageBase -5.4x adverse case -4.6x
Return on equity (ROE)Base -34.3% adverse case -30.4%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -5.4x adverse case -4.7x
Return on equity (ROE)Base -34.3% adverse case -35.6%

Interest coverage limit

Already below the limit by 213.1pp

Interest coverage limit at an operating margin of 33.2%

Interest expense coverage threshold

Xencor:“What if I buy at RSI 30?” 1 free card

Xencor notifications

Quantus Signal · live data · not investment advice · Privacy Policy